TASK III for Stroke Caregiver Support
Trial Summary
Do I need to stop taking my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on caregiver support rather than medication use.
What data supports the effectiveness of the TASK III treatment for stroke caregiver support?
Is the TASK III intervention safe for stroke caregivers?
How is the TASK III treatment for stroke caregiver support different from other treatments?
What is the purpose of this trial?
Caring for a family member after a stroke can be very difficult and worsen the physical and mental health of untrained caregivers. The TASK III intervention is a unique, comprehensive caregiver intervention program that enables caregivers to develop the necessary skills to manage care for the survivor, while also taking care of their own health.
Research Team
Tamilyn Bakas, PhD, RN
Principal Investigator
University of Cincinnati
Eligibility Criteria
This trial is for unpaid family caregivers of stroke survivors who can communicate in English and use a phone or computer. They must be willing to engage in 9 calls with a nurse and 5 interviews, have no severe cognitive impairments, and not care for someone in long-term facilities. Exclusions include caregivers or survivors with certain mental illnesses, substance abuse history, under age 18, incarcerated, pregnant, or terminally ill.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the TASK III intervention or are assigned to the ISR group, focusing on skill-building and self-management strategies
Follow-up
Participants are monitored for long-term efficacy of the intervention, including life changes and depressive symptoms
Treatment Details
Interventions
- Information Support and Referral (ISR) Group
- Telehealth Assessment and Skill-Building Kit (TASK III) Group
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Cincinnati
Lead Sponsor
National Institute of Nursing Research (NINR)
Collaborator